Sudarshan Pharma Q3FY26 earnings rise; stock sinks

Sudarshan Pharma reports Q3FY26 net sales of Rs 168 crore and net profit of Rs 4.36 crore, with 9MFY26 revenue up 40% and PAT up 67%, despite a 52-week stock low.